SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-16-164590
Filing Date
2016-12-30
Accepted
2016-12-30 16:31:29
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 a16-23901_1s3.htm S-3 564417
2 EX-4.1 a16-23901_1ex4d1.htm EX-4.1 463667
3 EX-4.3 a16-23901_1ex4d3.htm EX-4.3 170685
4 EX-4.4 a16-23901_1ex4d4.htm EX-4.4 169798
5 EX-4.5 a16-23901_1ex4d5.htm EX-4.5 146712
6 EX-5.1 a16-23901_1ex5d1.htm EX-5.1 15566
7 EX-5.2 a16-23901_1ex5d2.htm EX-5.2 23564
8 EX-23.1 a16-23901_1ex23d1.htm EX-23.1 2465
9 GRAPHIC g239011kui001.jpg GRAPHIC 2760
10 GRAPHIC g239011bci001.jpg GRAPHIC 2808
  Complete submission text file 0001104659-16-164590.txt   1566018
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 441-295-5950
Axovant Sciences Ltd. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: S-3 | Act: 33 | File No.: 333-215387 | Film No.: 162077853
SIC: 2834 Pharmaceutical Preparations